Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 1577 - 1584 of 12040 results
FDA Opens a Pilot Program to Scrutinize Certain Laboratory Developed Tests, But Will It Generate Sufficient Interest?
June 28, 2023| Blog| Viewpoint
New Levine Act Regulations – How Will They Affect You?
June 28, 2023| Advisory| Viewpoint
Better Late Than Never: Employers in Canada Should Review Their Termination of Employment Provisions
June 28, 2023| Blog| Viewpoint
Proposed Overhaul of HSR Premerger Notification Process
June 28, 2023| Blog| Viewpoint
EXCLUSIVE RIGHTS: Intellectual Property — Bad Dog? “Bad Spaniels” at SCOTUS
June 27, 2023| Podcast| Viewpoint
Cross-border Considerations for the Life Sciences Industry
June 27, 2023| Blog| Viewpoint
Recent Developments Signal Headwinds for Homeopathic Drug Products
June 26, 2023| Blog| Viewpoint
PE Exits A Growing Segment Of Deals With Earnout Provisions
June 26, 2023| News
News & Press Releases
Mintz Welcomes Corporate Member Ruth Jin in New York
July 21, 2025
Ruth Jin has joined Mintz as a Member in the firm’s Corporate Practice with a focus on investment fund formation, liquidity strategies, governance, investment transactions, and securities offerings.
San Francisco Business Times featured Mintz’s new office lease in San Francisco at 525 Market St. The firm will be increasing its footprint in downtown by 50% to 29,000 square feet on a whole single floor with the new space.
Mintz advised the underwriters in connection with a $230 million public offering by Cogent Biosciences, Inc. of 25,555,556 shares of common stock, which includes 3,333,333 shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock, offered at a public offering price of $9.00 per share. The aggregate gross proceeds to Cogent from this offering were approximately $230 million, including proceeds from the exercise in full by the underwriters of the option to purchase additional shares, before deducting underwriting discounts and commissions and other offering expenses.
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|